Patents Assigned to Genocea Biosciences, Inc.
  • TREATMENT METHODS
    Publication number: 20220412979
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Application
    Filed: October 29, 2019
    Publication date: December 29, 2022
    Applicant: Genocea Biosciences, Inc.
    Inventors: Jessica Baker Flechtner, Jason R. Dobson
  • Vaccines and compositions against
    Patent number: 11207375
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: December 28, 2021
    Assignees: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley
  • Antigen screening system
    Patent number: 11162093
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: November 2, 2021
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Baker Flechtner, Todd Gierahn
  • Treatment methods
    Patent number: 10859566
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: December 8, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 10653771
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: May 19, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Antigen screening system
    Patent number: 10570387
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: February 25, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Flechtner, Todd Gierahn
  • VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
    Publication number: 20190298795
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Application
    Filed: September 17, 2018
    Publication date: October 3, 2019
    Applicants: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley
  • Methods and compositions for treating herpes
    Patent number: 10350288
    Abstract: The present disclosure provides certain combinations of immunogenic compositions against HSV-2 and antiviral therapy. The vaccines can be used therapeutically and/or prophylactically.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: July 16, 2019
    Assignee: Genocea Biosciences, Inc.
    Inventor: Seth Vollmer Hetherington
  • Vaccines and compositions against
    Patent number: 10188717
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromized patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: January 29, 2019
    Assignees: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley
  • Vaccines and compositions against
    Patent number: 10105412
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: October 23, 2018
    Assignees: Genocea Biosciences, Inc., Chidlren's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9895436
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: February 20, 2018
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Antigen screening system
    Patent number: 9873870
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: January 23, 2018
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9782474
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2, which can be used therapeutically or prophylactically, are described.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: October 10, 2017
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • Fused antigen vaccines and compositions against
    Patent number: 9765125
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae that contain fusion proteins. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: September 19, 2017
    Assignees: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Jessica Flechtner, Richard Malley
  • Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 9624273
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2 which can be used therapeutically or prophylactically, are described.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: April 18, 2017
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne
  • Vaccines and compositions against
    Patent number: 9393294
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromized patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: July 19, 2016
    Assignees: Genocea Biosciences, Inc., Children's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley
  • Antigen screening system
    Patent number: 9045791
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: June 2, 2015
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20140227307
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: November 12, 2013
    Publication date: August 14, 2014
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
    Patent number: 8617564
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 31, 2013
    Assignee: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne, George R. Siber
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20130337000
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: November 23, 2011
    Publication date: December 19, 2013
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne